Hong Kong stock concept tracking | The end of medical insurance negotiations is very encouraging for innovative drugs to be included in medical insurance at reasonable prices (with concept stocks)

The on-site negotiation and bidding stages for the adjustment of the national medical insurance pharmaceutical catalog in 2024 officially ended recently.

Zhitong FinanceNov 3 20:45 ET

Is Shenzhen Hepalink Pharmaceutical Group (SZSE:002399) A Risky Investment?

Simply Wall StNov 1 19:47 ET

Historically the most 'competitive'? The Tenth Batch of National Procurement Pharmaceutical Catalog Is Officially Announced with one type having up to 31 companies competing.

①This afternoon, the National Pharmaceutical Joint Procurement Office officially announced the tenth batch of nationally purchased pharmaceutical catalog, with a total of 263 specifications and 62 varieties; ②Several industry insiders have stated that the tenth batch of national procurement will be the largest and most competitive national procurement in history.

cls.cnNov 1 08:59 ET

Shenzhen Hepalink Pharmaceutical Group Q3 Profit Rises 487%

MT NewswiresNov 1 03:24 ET

Highpree: Third quarter 2024 report

SZSIOct 30 12:00 ET · Announcements

Express News | Shenzhen Hepalink Pharmaceutical - Qtrly Rpofit Attributable RMB116.4 Mln

ReutersOct 30 05:27 ET